MgcRacGAP interacts with HIF-1α and regulates its transcriptional activity A Lyberopoulou, E Venieris, I Mylonis, G Chachami, I Pappas, G Simos, ... Cellular Physiology and Biochemistry 20 (6), 995-1006, 2007 | 68 | 2007 |
Prompt initiation of high‐dose iv corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis K Zachou, P Arvaniti, K Azariadis, V Lygoura, NK Gatselis, ... Hepatology Research 49 (1), 96-104, 2019 | 58 | 2019 |
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B M Papatheodoridi, E Hadziyannis, F Berby, K Zachou, B Testoni, ... Journal of Viral Hepatitis 27 (2), 118-126, 2020 | 49 | 2020 |
TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting G Fountzilas, E Giannoulatou, Z Alexopoulou, F Zagouri, E Timotheadou, ... Oncotarget 7 (22), 32731, 2016 | 44 | 2016 |
Low serum hepcidin in patients with autoimmune liver diseases A Lyberopoulou, G Chachami, NK Gatselis, E Kyratzopoulou, A Saitis, ... PloS one 10 (8), e0135486, 2015 | 32 | 2015 |
Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation S Drakouli, A Lyberopoulou, M Papathanassiou, I Mylonis, E Georgatsou The FEBS Journal 284 (15), 2482-2500, 2017 | 25 | 2017 |
Impact of genetic and environmental factors on autoimmune hepatitis K Zachou, P Arvaniti, A Lyberopoulou, GN Dalekos Journal of Translational Autoimmunity 4, 100125, 2021 | 23 | 2021 |
MgcRacGAP, a cytoskeleton regulator, inhibits HIF-1 transcriptional activity by blocking its dimerization A Lyberopoulou, I Mylonis, G Papachristos, D Sagris, A Kalousi, C Befani, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (6), 1378-1387, 2013 | 22 | 2013 |
An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis G Chachami, A Kalousi, L Papatheodorou, A Lyberopoulou, V Nasikas, ... PLoS One 8 (11), e79647, 2013 | 17 | 2013 |
Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA V Kotoula, A Lyberopoulou, K Papadopoulou, E Charalambous, ... PloS one 10 (6), e0128818, 2015 | 16 | 2015 |
Epigenetic modifications in generalized autoimmune epithelitis: Sjögren’s syndrome and primary biliary cholangitis P Arvaniti, K Zachou, A Lyberopoulou, NK Gatselis, WH Brooks, ... Epigenomes 3 (3), 15, 2019 | 15 | 2019 |
Significance of serum HBV RNA in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients who discontinue effective antiviral therapy M Papatheodoridi, E Papachristou, Z Moschidis, E Hadziyannis, ... Journal of Viral Hepatitis 29 (11), 948-957, 2022 | 12 | 2022 |
Soluble IL-2R levels at baseline predict the development of severe respiratory failure and mortality in COVID-19 patients NK Gatselis, V Lygoura, A Lyberopoulou, G Giannoulis, A Samakidou, ... Viruses 14 (4), 787, 2022 | 12 | 2022 |
Recent advances in the diagnosis and management of autoimmune hepatitis GN Dalekos, A Samakidou, A Lyberopoulou, E Banakou, NK Gatselis Polish archives of internal medicine 132 (9), 16334, 2022 | 9 | 2022 |
Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis K Zachou, P Arvaniti, A Lyberopoulou, E Sevdali, M Speletas, M Ioannou, ... Liver International 42 (6), 1355-1368, 2022 | 6 | 2022 |
Investigating the Clinical Relevance of Genomic Characteristics in Luminal a and B Breast Cancer (Bc) V Kotoula, F Zagouri, E Timotheadou, Z Alexopoulou, R Wirtz, ... Annals of Oncology 25, iv87, 2014 | 6 | 2014 |
Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis NK Gatselis, K Azariadis, A Lyberopoulou, GN Dalekos Journal of Translational Autoimmunity 4, 100126, 2021 | 5 | 2021 |
Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study NK Gatselis, A Lyberopoulou, V Lygoura, G Giannoulis, A Samakidou, ... European Journal of Internal Medicine 122, 78-85, 2024 | 3 | 2024 |
Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients … M Papatheodoridis, E Rigopoulou, E Hadziyannis, Z Kalliopi, V Xourafas, ... Journal of Hepatology 68, S88-S89, 2018 | 3 | 2018 |
Oxygen-dependent secretion of a bioactive hepcidin-GFP chimera G Chachami, A Lyberopoulou, A Kalousi, E Paraskeva, K Pantopoulos, ... Biochemical and Biophysical Research Communications 435 (4), 540-545, 2013 | 3 | 2013 |